Senseonics Holdings (SENS) Tops Q3 EPS by 16c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Senseonics Holdings (SENS) Tops Q3 EPS by 16c

Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results

November 9, 2021 4:05 PM EST

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2021.

Recent Highlights & Accomplishments:

Generated third quarter 2021 revenue of $3.5 million FDA active review of the Eversense® 180-day PMA supplement application continues Presented clinical data on the safety and accuracy of Eversense at the European Association for the Study of Diabetes Annual Meeting, Association of... More